Benchmarking Peptide-Protein Affinity Prediction Across Peptide and Target Shifts
Read the original on arXiv Machine Learning →The Flow has not summarised this story yet — read it at arXiv Machine Learning.
The Flow has not summarised this story yet — read it at arXiv Machine Learning.
arXiv:2607. 05846v1 Announce Type: cross Abstract: Accurate ranking of antibody candidates according to their binding affinity is essential for therapeutic antibody discovery.
The study investigates how different distribution shifts affect the evaluation of drug‑target affinity (DTA) models, using 718,800 drug‑protein pairs from ChEMBL and BindingDB. It compares a baseline Morgan‑fingerprint + protein‑CNN model with 12 architectures that combine four drug representations and three ESM‑2 interaction modes, finding that mean validation RMSE rises significantly under protein‑cluster and dual out‑of‑distribution (OOD) scenarios. Model rankings remain consistent across chemical shifts but diverge under protein and dual OOD, indicating that architecture selection depends on the specific extrapolation context rather than just average error or training‑set size. Why it matters: The results suggest that DTA benchmarks should be designed to reflect the chemical and target shifts expected in real deployment, ensuring that chosen models perform reliably when applied to new chemical series or protein targets.
Accurate ranking of antibody candidates according to their binding affinity is essential for therapeutic antibody discovery. However, existing methods treat affinity comparisons independently and ignore the contextual information encoded in other labeled comparisons, limiting their ability to capture antigen-specific binding landscapes.
arXiv:2604.18467v3 Announce Type: replace-cross Abstract: Motivation: Peptide-protein interactions (PepPIs) are central to cellular regulation and peptide therapeutics, but experimental characterizat...
arXiv:2606. 11868v1 Announce Type: new Abstract: De novo peptide sequencing from tandem mass spectrometry is pivotal in proteomics, enabling identification of novel peptides without reference databases.
arXiv:2608.21367v1 Announce Type: cross Abstract: Protein-peptide interactions are central to cellular regulation and peptide-based drug discovery, yet existing computational methods mainly focus on...